Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InnovAge Holding (INNV) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for InnovAge Holding (INNV) over the last 6 years, with Q4 2025 value amounting to $2.4 million.

  • InnovAge Holding's Capital Expenditures rose 7594.94% to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.2 million, marking a year-over-year increase of 2547.95%. This contributed to the annual value of $6.3 million for FY2025, which is 2086.18% down from last year.
  • According to the latest figures from Q4 2025, InnovAge Holding's Capital Expenditures is $2.4 million, which was up 7594.94% from $4.1 million recorded in Q3 2025.
  • InnovAge Holding's 5-year Capital Expenditures high stood at $18.1 million for Q2 2022, and its period low was -$179000.0 during Q2 2025.
  • For the 5-year period, InnovAge Holding's Capital Expenditures averaged around $4.4 million, with its median value being $3.2 million (2021).
  • Within the past 5 years, the most significant YoY rise in InnovAge Holding's Capital Expenditures was 54137.17% (2025), while the steepest drop was 10541.6% (2025).
  • Quarter analysis of 5 years shows InnovAge Holding's Capital Expenditures stood at $8.6 million in 2021, then fell by 19.37% to $7.0 million in 2022, then tumbled by 77.23% to $1.6 million in 2023, then decreased by 15.32% to $1.3 million in 2024, then soared by 75.95% to $2.4 million in 2025.
  • Its Capital Expenditures stands at $2.4 million for Q4 2025, versus $4.1 million for Q3 2025 and -$179000.0 for Q2 2025.